In a new study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25), South Korean researchers report that for patients at high risk for bleeding following stent ...

A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) ...

also lays out more bleed-safe alternatives to the standard DAPT regimen for people with unstable angina, non-ST segment ...

DAPT for 3 months was superior to 12 months for patients with low bleeding risk. CHICAGO — Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in ...

While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially ...

The guideline focuses on the management of unstable angina and myocardial infarction – both non-ST ... Dual antiplatelet therapy (DAPT), comprising aspirin plus a P2Y12 inhibitor, is already ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT ... elevation myocardial infarction (STEMI) and ...

was associated with favorable outcomes in patients with stabilized acute myocardial infarction (AMI) having a body mass index (BMI) less than 28 but not in those with a higher BMI. This post hoc ...

Following cardiac catheterization, patients with ST-segment elevation myocardial infarction (STEMI) have a higher risk of short-term mortality than patients with non-STEMI (NSTEMI), who have a ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with ...